REGN vs WT · P/E 14, rev $14.34B vs P/E 44, rev $427.7M
Regeneron Pharmaceuticals Inc (REGN) versus WisdomTree Inc. (WT) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
WisdomTree Inc. (WT) is a asset management company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported WT revenue for 2024-12-31 was $427.7M. Net income was $66.7M. Revenue was up 22.5% from 2023-12-31 to 2024-12-31. WT currently screens at market cap $2.78B and trailing P/E 44.3.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. WT currently screens at market cap $2.78B and trailing P/E 44.3.
Not investment advice. Open the REGN and WT stock pages for the full models.
Not investment advice.